Lotus Pharmaceutical (Taiwan) Investor Sentiment

1795 Stock  TWD 271.50  4.00  1.45%   
Slightly above 61% of Lotus Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Lotus Pharmaceutical Co suggests that many traders are alarmed regarding Lotus Pharmaceutical's prospects. Lotus Pharmaceutical's investing sentiment can be driven by a variety of factors including economic data, Lotus Pharmaceutical's earnings reports, geopolitical events, and overall market trends.
Lotus Pharmaceutical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Lotus daily returns and investor perception about the current price of Lotus Pharmaceutical Co as well as its diversification or hedging effects on your existing portfolios.
  
over a month ago at news.google.com         
PTT set to spin off life science unit Innobic - Bangkok Post
Google News at Macroaxis
over a month ago at news.google.com         
Lotus Pharmaceutical Co., Ltd. Just Reported Third-Quarter Earnings Have Analysts Changed Their Mind...
Google News at Macroaxis
over a month ago at news.google.com         
Lotus Pharmaceutical Co., Ltd. Just Reported Third-Quarter Earnings Have Analysts Changed Their Mind...
Google News at Macroaxis
over two months ago at news.google.com         
Multibagger Stock Mukesh Ambani-backed small-cap surges 400 percent in 4 months, 5,062 percent in 3 ...
Google News at Macroaxis
over three months ago at news.google.com         
Lotus Chocolate Companys Stock Reaches All-Time High, Outperforms Sector by 4.95 percent - MarketsMo...
Google News at Macroaxis
over three months ago at news.google.com         
Lotus Chocolate Companys Stock Reaches 52-Week High, Outperforms Sector by 4.79 percent - MarketsMoj...
Google News at Macroaxis
over three months ago at news.google.com         
Lotus Chocolate Company - Concurrent Gainers These 6 stocks gained for 5 days in a row - The Economi...
Google News at Macroaxis
over three months ago at news.google.com         
Should You Buy Lotus Pharmaceutical Co., Ltd. For Its Upcoming Dividend - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Lotus Pharmaceutical Honored 2024 Taiwan BIO Awards- Outstanding Company of the Year, Showcasing Exc...
Google News at Macroaxis
over three months ago at news.google.com         
Investors Continue Waiting On Sidelines For Lotus Pharmaceutical Co., Ltd. - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Nrx Pharmaceuticals, Inc. Receives A Notice of Termination of Exclusive, Global Development, Supply,...
Google News at Macroaxis
over six months ago at news.google.com         
Lotus Pharmaceutical Co., Ltd.s biggest owners are retail investors who got richer after stock soare...
Google News at Macroaxis
over six months ago at news.google.com         
Could The Market Be Wrong About Lotus Pharmaceutical Co., Ltd. Given Its Attractive Financial Prospe...
Google News at Macroaxis
over six months ago at news.google.com         
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024 - StockTitan
Google News at Macroaxis
over six months ago at news.google.com         
Nrx plans suicidal bipolar depression study despite phase IIIII trouble - BioWorld Online
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Lotus Pharmaceutical that are available to investors today. That information is available publicly through Lotus media outlets and privately through word of mouth or via Lotus internal channels. However, regardless of the origin, that massive amount of Lotus data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lotus Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lotus Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lotus Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lotus Pharmaceutical alpha.

Lotus Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Lotus Stock Analysis

When running Lotus Pharmaceutical's price analysis, check to measure Lotus Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceutical is operating at the current time. Most of Lotus Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceutical's price. Additionally, you may evaluate how the addition of Lotus Pharmaceutical to your portfolios can decrease your overall portfolio volatility.